谷歌浏览器插件
订阅小程序
在清言上使用

Ctdna Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or Without Bevacizumab from the Randomised Phase II ETOP-BOOSTER Trial

Clinical cancer research an official journal of the American Association for Cancer Research(2024)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要